NCT06784765View on ClinicalTrials.gov

Preventive Use of PIPAC in Locally Advanced Gastric Cancer.

NARecruitingINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

January 15, 2025

Primary Completion Date

December 30, 2026

Study Completion Date

December 1, 2027

Conditions
Gastric Cancer
Interventions
PROCEDURE

Intervention Group

Preventive pressurized intraperitoneal aerosol chemotherapy (PIPAC) with cisplatin (10 mg/m2) and doxorubicin (2.1 mg/m2) + perioperative chemotherapy (FLOT regimen) +gastrectomy with D2 lymphadenectomy

PROCEDURE

Control Group

Retrospective cohort receiving standard perioperative chemotherapy (FLOT regimen) + gastrectomy with D2 lymphadenectomy

Trial Locations (1)

010000

RECRUITING

National Research Oncology Centre, Astana

All Listed Sponsors
collaborator

Ministry of Science and Higher Education of the Republic of Kazakhstan

OTHER_GOV

lead

National Research Oncology and Transplantology Center, Kazakhstan

OTHER

NCT06784765 - Preventive Use of PIPAC in Locally Advanced Gastric Cancer. | Biotech Hunter | Biotech Hunter